<?xml version="1.0" encoding="UTF-8"?>
<ref id="CR26">
 <label>26.</label>
 <element-citation publication-type="journal">
  <person-group person-group-type="author">
   <name>
    <surname>Borden</surname>
    <given-names>KL</given-names>
   </name>
   <name>
    <surname>Culjkovic-Kraljacic</surname>
    <given-names>B</given-names>
   </name>
  </person-group>
  <article-title>Ribavirin as an anti-cancer therapy: acute myeloid leukemia and beyond?</article-title>
  <source>Leuk Lymphoma</source>
  <year>2010</year>
  <volume>51</volume>
  <issue>10</issue>
  <fpage>1805</fpage>
  <lpage>15</lpage>
  <pub-id pub-id-type="doi">10.3109/10428194.2010.496506</pub-id>
  <?supplied-pmid 20629523?>
  <pub-id pub-id-type="pmid">20629523</pub-id>
 </element-citation>
</ref>
